BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32141094)

  • 21. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estimated cause-specific survival continues to improve over time in patients with chondrosarcoma.
    Duchman KR; Lynch CF; Buckwalter JA; Miller BJ
    Clin Orthop Relat Res; 2014 Aug; 472(8):2516-25. PubMed ID: 24706044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical pathological significance of FRAT1 and ROR2 expression in cartilage tumors.
    He L; Yang Z; Zhou J; Wang W
    Clin Transl Oncol; 2015 Jun; 17(6):438-45. PubMed ID: 25387569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
    Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
    J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of aurora kinase A and B in chondrosarcoma and its relationship with the prognosis.
    Liang X; Wang D; Wang Y; Zhou Z; Zhang J; Li J
    Diagn Pathol; 2012 Jul; 7():84. PubMed ID: 22809428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chondrosarcoma of the pelvis.
    Ozaki T; Hillmann A; Lindner N; Blasius S; Winkelmann W
    Clin Orthop Relat Res; 1997 Apr; (337):226-39. PubMed ID: 9137194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chondrosarcoma of bone: an assessment of outcome.
    Lee FY; Mankin HJ; Fondren G; Gebhardt MC; Springfield DS; Rosenberg AE; Jennings LC
    J Bone Joint Surg Am; 1999 Mar; 81(3):326-38. PubMed ID: 10199270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990.
    Söderström M; Ekfors TO; Böhling TO; Teppo LH; Vuorio EI; Aro HT
    Acta Orthop Scand; 2003 Jun; 74(3):344-50. PubMed ID: 12899557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and prognostic factors in conventional G1 chondrosarcoma.
    Fromm J; Klein A; Baur-Melnyk A; Knösel T; Lindner L; Birkenmaier C; Roeder F; Jansson V; Dürr HR
    World J Surg Oncol; 2019 Sep; 17(1):155. PubMed ID: 31481076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sixty percent 10-year survival of patients with chondrosarcoma after local recurrence.
    Lin PP; Alfawareh MD; Takeuchi A; Moon BS; Lewis VO
    Clin Orthop Relat Res; 2012 Mar; 470(3):670-6. PubMed ID: 21918803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
    Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
    Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marital Status and Survival of Patients with Chondrosarcoma: A Population-Based Analysis.
    Gao Z; Ren F; Song H; Wang Y; Wang Y; Gao Z; Zhu J; He X
    Med Sci Monit; 2018 Sep; 24():6638-6648. PubMed ID: 30235178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the behaviour of chondrosarcoma of bone.
    Sanerkin NG; Gallagher P
    J Bone Joint Surg Br; 1979 Nov; 61-B(4):395-400. PubMed ID: 500746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis.
    Nakagawa SA; Lopes A; Lopes de Carvalho A; Rossi BM; Werneck da Cunha I; Soares FA; Chung WT; Alves LA
    J Bone Joint Surg Am; 2010 Jul; 92(8):1738-46. PubMed ID: 20660237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Resection of the Primary Tumor Improve Survival in Patients With Metastatic Chondrosarcoma?
    Song K; Song J; Chen F; Lin K; Ma X; Jiang J
    Clin Orthop Relat Res; 2019 Mar; 477(3):573-583. PubMed ID: 30762691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging of chondrosarcoma with histopathological and prognostic correlation. An analysis of 49 cases mainly based on plain film radiography.
    Jurik AG; Jensen O; Keller J; Nielsen OS; Lundorf E; Daugaard S; Sneppen O
    Rofo; 1995 Nov; 163(5):372-7. PubMed ID: 8527748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence, outcomes and prognostic factors during 25 years of treatment of chondrosarcomas.
    van Praag Veroniek VM; Rueten-Budde AJ; Ho V; Dijkstra PDS; ; Fiocco M; van de Sande MAJ
    Surg Oncol; 2018 Sep; 27(3):402-408. PubMed ID: 30217294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.